Label Image (Lbl500900761)
Lovastatin Tablet
Product Images NDC 50090-0761
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 50090-0761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula (Lov00 0004 01)
Table I (Lov00 0004 02)
Figure 1 (Lov00 0004 03)
The text describes a figure labeled “Figure 1” showing the proportion of participants without an acute major coronary event (primary endpoint) over 4 years of follow-up.*
Table Vii (Lov00 0005 04)
This is a drug interaction table that shows prescribed medications that must be avoided or used with caution to prevent increased risk of myopathy/rhabdomyolysis. These interactions are associated with certain drugs, such as Strong CYP3A4 inhibitors, HIV protease inhibitors, Telaprevir, and others. The table also includes prescribing recommendations, such as avoiding or not exceeding a certain dose for specific drugs like Gemfibrozil or Lovastatin, and avoiding grapefruit juice.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
